Bacteriophages are viruses that specifically target and destroy bacterial cells. Cytophage uses synthetic biology to generate any type of bacteriophage in the lab, replacing that ‘search-in-nature’ process and accelerating the development and application of bacteriophages to prevent or treat infections. This would serve as a complement to antibiotics and help tackle the global problem of antibiotic resistance. Our vision for Cytophage is that every hospital, every veterinarian and every agricultural facility will have a supply of Cytophage products to manage any incumbent or emergent bacterial infection or contamination.
Company Details
- Employees
- 15
- Founded
- 2017
- Address
- 26 Henlow Bay, Winnipeg,manitoba R3y 1g4,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cytophage.com
- Keywords
- antimicrobial resistance, AMR, super bugs, animal health, human health, phages, phage therapy, bacteriophage, antibiotics.
- HQ
- Winnipeg, Manitoba
Cytophage Technologies Ltd. Questions
Cytophage Technologies Ltd.'s website is cytophage.com
Cytophage Technologies Ltd.'s LinkedIn profile is https://ca.linkedin.com/company/cytophagetech
Cytophage Technologies Ltd. has
15 employees.
View email and phone details for 15
employees at Cytophage Technologies Ltd..
Cytophage Technologies Ltd.'s industry is
Biotechnology Research
Cytophage Technologies Ltd.'s top competitors are
Bioscience Association Manitoba,
Virica Biotech,
Kane Biotech Inc.,
Cancercare Manitoba,
Phageguard,
Shield Therapeutics Plc,
Research Manitoba,
Women In Bacteriophage,
Adaptive Phage Therapeutics,
Triera Biosciences.
Cytophage Technologies Ltd.'s categories are Biotechnology Research
Cytophage Technologies Ltd.'s founding year is 2017
